don’t want to get into the directors and personal happenings but basically a whole lot of hot air interviews tv, radio etc that revolved around flim flam , spin doctoring and fluff. Many shareholders entered into it from 40/50c range only to see it collapse to at one stage below 6c , Aust results never came up to FDA standards for a whole lot of botched and hurried tests, can you imagine doing a cough sound test in a crowded hospital with noise everywhere, just one example. I believe the only reason Pfizer bought the tech was to shelve it to protect their countless billions in drugs that were at risk of losing if the tech worked out. No more from me on this thread, just beware peeps. I might add that on HC which had a massive RAP following almost to a man were voting against the takeover yet it managed to get up?.. still a mystery that one.
- Forums
- ASX - By Stock
- BB1
- The float
The float, page-65
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
Add BB1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $15.69M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 27.5¢ | $17.67K | 63.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 42703 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 74725 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 39000 | 0.270 |
1 | 29754 | 0.265 |
1 | 10000 | 0.255 |
2 | 30000 | 0.250 |
2 | 120833 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 74725 | 1 |
0.295 | 20000 | 1 |
0.330 | 15002 | 1 |
0.340 | 39501 | 2 |
0.345 | 2500 | 1 |
Last trade - 14.47pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
BB1 (ASX) Chart |